A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

A single invitation for a prostate-specific antigen (PSA) screening test results in a small but significant reduction in prostate cancer deaths, but also leads to overdiagnosis and missed early ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...

This is a large-scale, population-based, observational study of two screening strategies: annual PSA screening and no screening. We used data from 537,599 US Medicare (2001-2008) beneficiaries age ...

PSA-based screening significantly decreases the risk of dying from prostate cancer (PCa), according to updated results of a large European study. The European Randomized Study of Screening for ...

SAN FRANCISCO—Offering PSA testing for free is associated with a reduction in prostate cancer mortality, according to an Austrian study. The study, presented at the American Urological Association ...

PSA screening appeared associated with lower prostate cancer-specific mortality among both black men and non-Hispanic white men, according to study results published in JAMA Oncology. However, annual ...

Advanced prostate cancer incidence and associated mortality rates have been increasing in California since the 2010s, according to the authors of a new study. These concerning trends may be partly ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

While the benefits of screening tests for cervical cancer, breast cancer, and colorectal cancer are widely accepted, screening for prostate cancer remains controversial to some. The main screening ...